Dawnrays Pharmaceutical (Holdings) Limited announced that due to health reason, Mr. Li Tung Ming has rendered his resignation as executive director of the Company and also resigned directorship of Suzhou Dawnrays Pharmaceutical Co. Ltd., Su Zhou Dawnrays Pharmaceutical Science and Technology Co. Ltd., Dawnrays (Nantong) Pharmaceutical Science and Technology Co. Ltd. and Guangdong Dawnrays Pharmaceutical Co. Ltd., all are wholly-owned subsidiaries of the Company, with effect from 23 February 2018 respectively. However, Mr. Li will continually endeavor to assist in the liaison with the academic network of medical experts and academic advisers and assist in new product development for the Company.